EBS Technology GmbH, a Kleinmachnow-Germany based company that develops medical devices for the treatment of neurological deficits that result from stroke or brain trauma, completed its €3m Series B financing round.
The round was led by Earlybird, with participation from BFB Wachstumsfonds Brandenburg of InvestitionsBank des Landes Brandenburg, which is managed by BC Brandenburg Capital (BC) and High-Tech Gründerfonds.
The new funds will enable the company to bring the medical device to market approval. In parallel, further clinical trials for additional indications will be conducted.
Established in 2007, the company received a seed financing from High-Tech Gründerfonds in 2008, which enabled the development of a prototype device which is approved for the use in clinical studies.